KD025 is a casein kinase 2 inhibitor that protects against glucolipotoxicity in beta cells
Consortia: CTAR
Devkota R, Small JC, Carbone K, Glass MA, Vetere A, Wagner BK.
Diabetes. 2024 Jan 11:db230506. doi: 10.2337/db23-0506. PMID:38211571
Consortia: CTAR
Devkota R, Small JC, Carbone K, Glass MA, Vetere A, Wagner BK.
Diabetes. 2024 Jan 11:db230506. doi: 10.2337/db23-0506. PMID:38211571